归创通桥医疗科技股份有限公司（股票代码：2190）于2025年12月2日发布截至2025年11月30日的股份变动月报表。公告显示，公司注册股本本月底为344,132,001股，其中H股注册股本由上月底的322,400,744股增至336,350,744股，内资股7,781,257股维持不变。
本月底已发行H股329,504,613股，与上月底的315,804,613股相比，新增13,700,000股；库存H股则从6,596,131股增至6,846,131股。公司于2025年5月30日购回250,000股H股并将其持作库存。本月还涉及13,950,000份受限制股份单位授出事项，相关金额已计入当月新增发行股份总数。
截至2025年11月30日，公司H股及内资股合计股本数为344,132,001股。公司在公告中确认上述变动均已获董事会正式授权，并遵守香港联交所《上市规则》及相关法律规定。公告由公司董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.